基于诊断转化风险的开角型青光眼疑似者风险分层监测
该回顾性队列研究纳入2007至2021年美国83 305例新诊断开角型青光眼疑似者,20.6%转化为原发性开角型青光眼,总体年转化率6.1%(第1年9.4%,第2-5年5.3%)。年龄、性别、种族、地区、房角镜检查记录及治疗状态与转化风险相关,按每次访视转化风险分层可安全调整随访频率。
要点
- 开角型青光眼疑似者总体年转化率6.1%,第1年9.4%,第2-5年5.3%。
- 高龄、男性、黑人种族、东北部以外地区、房角镜检查记录及治疗状态与更高转化风险相关。
- 按每次访视5.0%转化阈值标准化,最低危组监测间隔6.1年,最高危组0.6年。
核心结论
- 开角型青光眼疑似者诊断后第1年转化率较高,此后年转化率低于6.0%。
- 基于每次访视转化风险估计可实施风险分层监测策略,可能安全减少极低危患者访视频率。
研究设计与样本
- 回顾性队列研究,数据来自Optum去标识化Clinformatics Data Mart数据库。
- 纳入2007至2021年新诊断开角型青光眼疑似者83 305例,需连续入组及眼科医生或视光师诊断并至少一次OCT或视野检查。
- 采用Cox比例风险模型评估与转化为原发性开角型青光眼相关的因素。
主要发现
- 83 305例中17 134例(20.6%)转化为原发性开角型青光眼。
- 总体年转化率6.1%,第1年9.4%,第2-5年5.3%。
- 多变量Cox回归显示年龄较大(HR≥1.38)、男性(HR=1.12)、黑人种族(HR=1.14)、东北部以外地区(HR≥1.24)、房角镜检查记录(HR=1.90)及疑似者治疗(HR≥1.31)与更高转化风险相关(P≤.02)。
- 最低危组(<50岁;未治疗)年转化率2.0%,随访间隔0.9±0.6年;最高危组(>70岁;治疗)第1年后年转化率16.7%,随访间隔0.4±0.4年。
- 按每次访视5.0%转化阈值标准化,最低危组和最高危组对应监测间隔分别为6.1年和0.6年。
关键数值与推荐
- 每次访视转化风险阈值设定为5.0%时,最低危组监测间隔6.1年,最高危组0.6年。
- 最低危组定义为<50岁且未治疗,最高危组定义为>70岁且治疗。
临床怎么用
- 可根据年龄、治疗状态等风险因素估计每次访视转化风险,个体化调整开角型青光眼疑似者随访频率。
- 对极低危患者可考虑延长随访间隔,对高危患者保持较短间隔以及时发现转化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess annual rates and determinants of diagnostic conversion from open angle glaucoma suspects (OAGS) to primary open angle glaucoma (POAG) in the United States and develop a pragmatic, risk-stratified framework for tailoring follow-up frequency based on per-visit conversion risk. DESIGN: Retrospective cohort study. METHODS: Patients with newly diagnosed OAGS between 2007 and 2021 were identified in Optum's de-identified Clinformatics Data Mart Database based on International Classification of Diseases codes. Inclusion required (1) continuous enrollment during a 3-year lookback period and 5-year study period from index (first) date of OAGS diagnosis, (2) diagnosis by an ophthalmologist or optometrist with ≥1 optical coherence tomography (OCT) or visual field test, and (3) no prior glaucoma-specific treatment or POAG diagnosis. Cox proportional hazards modeling was performed to assess factors associated with diagnostic conversion to POAG. In a secondary analysis, subgroups were created based on age and treatment status and predicted probability of conversion was estimated for each group. MAIN OUTCOME(S) AND MEASURE(S): Diagnostic conversion of POAG. RESULTS: Among 83 305 OAGS patients (57.6% female; 5.4% Asian; 11.1% Black; 12.7% Hispanic; 70.8% non-Hispanic White), 17 134 (20.6%) converted to POAG, corresponding to an overall annual conversion rate of 6.1% (9.4% in year 1, 5.3% in years 2-5). On multivariable Cox regression, older age (HR ≥ 1.38), male sex (HR = 1.12), Black race (HR = 1.14), location outside the Northeast (HR ≥ 1.24), record of gonioscopy (HR = 1.90), and OAGS treatment (HR ≥ 1.31) were associated with greater hazard of conversion (P ≤ .02). Among the lowest-risk patients (<50 years; untreated), annual conversion was 2.0% with follow-up every 0.9 ± 0.6 years, whereas the highest-risk patients (>70 years; treated) had a 16.7% annual conversion rate with follow-up every 0.4 ± 0.4 years after year 1. When standardized to a 5.0% per-visit conversion threshold, corresponding monitoring intervals were 6.1 years and 0.6 years, respectively. CONCLUSIONS: The rate of conversion from OAGS to POAG is <6.0% per year beyond the first year after diagnosis. Estimating per-visit conversion risk enables risk-stratified surveillance strategies that may safely reduce visit frequency for very low-risk patients while preserving timely detection in higher-risk groups, thereby improving clinical efficiency and resource allocation.
引用
- Yoo K, Wu L, James A, et al. Risk-Stratified Monitoring of Open Angle Glaucoma Suspects Based on Diagnostic Conversion Risk. Am J Ophthalmol. 2026. PMID: 42242412. doi:10.1016/j.ajo.2026.05.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。